Daiichi sues Seattle Genetics over tech used in high-profile ADC

Daiichi sues Seattle Genetics over tech used in high-profile ADC

Submitted by admin on November 5, 2019 - 10:34am
Source: 
Fierce Biotech
News Tags: 
Daiichi Sankyo
Seattle Genetics
antibody-drug conjugate
AstraZeneca
DS-8201
Headline: 
Daiichi sues Seattle Genetics over tech used in high-profile ADC
snippet: 

Daiichi Sankyo has started legal action against Seattle Genetics. The case centers on linker technology used in antibody-drug conjugates (ADCs) including Daiichi’s AstraZeneca-partnered DS-8201.

Do Not Allow Advertisers to Use My Personal information